These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 15235686

  • 1. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS.
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [Abstract] [Full Text] [Related]

  • 2. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA.
    N Engl J Med; 1999 Mar 25; 340(12):901-7. PubMed ID: 10089183
    [Abstract] [Full Text] [Related]

  • 3. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ, PREVENT Investigators.
    N Engl J Med; 2003 Apr 10; 348(15):1425-34. PubMed ID: 12601075
    [Abstract] [Full Text] [Related]

  • 4. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W, Warfarin Optimal Duration Italian Trial Investigators.
    N Engl J Med; 2001 Jul 19; 345(3):165-9. PubMed ID: 11463010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
    Schulman S, Lindmarker P.
    N Engl J Med; 2000 Jun 29; 342(26):1953-8. PubMed ID: 10874063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S.
    Thromb Haemost; 2002 Jan 29; 87(1):7-12. PubMed ID: 11848459
    [Abstract] [Full Text] [Related]

  • 11. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII.
    Eischer L, Gartner V, Schulman S, Kyrle PA, Eichinger S, AUREC-FVIII investigators.
    Ann Hematol; 2009 May 29; 88(5):485-90. PubMed ID: 18931845
    [Abstract] [Full Text] [Related]

  • 12. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B, Palareti G.
    Semin Vasc Med; 2003 Aug 29; 3(3):303-14. PubMed ID: 15199464
    [Abstract] [Full Text] [Related]

  • 13. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Aug 29; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Duration of anticoagulation after first episode of unprovoked venous thromboembolism.
    Abdel-Razeq HN, Radwi GR.
    Saudi Med J; 2004 Nov 29; 25(11):1776; author reply 1776-7. PubMed ID: 15573235
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outpatient management of anticoagulation therapy.
    du Breuil AL, Umland EM.
    Am Fam Physician; 2007 Apr 01; 75(7):1031-42. PubMed ID: 17427618
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar 01; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.